Vote Scores
Filings read through

Kobayashi Pharmaceutical Co., Ltd.: how funds voted at the meeting of 27 Mar 2026

Meeting
Season
year to 30 June 2026
Filers reporting
31
Ballot items
8

31 filers on Form N-PX reported votes at the Kobayashi Pharmaceutical Co., Ltd. meeting of 27 Mar 2026. The records fall into 8 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    11 nominees. 91.7% of the reported votes are for. 16 filers withheld from or voted against at least one nominee.

    519 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  2. Item 2: Director elections (nominees put forward by security holders)

    1 nominee. 0.0% of the reported votes are for. 2 filers withheld from or voted against at least one nominee.

    5 vote records from 3 filers. 0 of the 2 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of one fund family
    • Abstain or withhold 1
  3. Item 3: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    96 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    57 vote records from 31 filers. 0 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 15
  5. Item 5: Amend Articles to Add Provision on Product Quality Control and Safety

    48 vote records from 31 filers. 2 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 1
    • Against 14
    • Against management 1
  6. Item 6: Shareholder Proposal Regarding Outside Board Chair

    48 vote records from 31 filers. 15 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 9
    • Against 6
    • Against management 9
  7. Item 7: Amend Articles to Provide Monthly Reports to Outside Directors

    48 vote records from 31 filers. 2 of the 30 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 15 fund families
    • For 1
    • Against 14
    • Against management 1
  8. Item 8: Shareholder proposal: CORPORATE GOVERNANCE

    43 vote records from 28 filers. 26 of the 28 filers that marked the item voted against management.

    • Positions of 14 fund families
    • Against 1
    • Abstain or withhold 13
    • Against management 13

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Kobayashi Pharmaceutical Co., Ltd., meeting of 27 Mar 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family5. Proposal6. Proposal7. Proposal8. Proposal
BlackRock and iSharesAgainstAgainstAgainstAgainst
BNY MellonAgainstFor, against managementAgainstAbstain, against management
Charles SchwabFor, against managementFor, against managementFor, against managementNo report
EquitableAgainstFor, against managementAgainstAbstain, against management
FidelityAgainstAgainstAgainstAbstain, against management
Franklin TempletonAgainstFor, against managementAgainstAbstain, against management
Goldman SachsAgainstFor, against managementAgainstAbstain, against management
InvescoAgainstFor, against managementAgainstAbstain, against management
MFSAgainstFor, against managementAgainstAbstain, against management
Morgan Stanley, Eaton Vance and CalvertAgainstFor, against managementAgainstAbstain, against management
Northern Trust and FlexSharesAgainstAgainstAgainstAbstain, against management
Nuveen and TIAAAgainstAgainstAgainstAbstain, against management
PIMCOAgainstFor, against managementAgainstAbstain, against management
State Street and SPDRAgainstAgainstAgainstAbstain, against management
VanguardAgainstAgainstAgainstAbstain, against management

Questions

How many filers reported votes at the Kobayashi Pharmaceutical Co., Ltd. meeting?
31 Form N-PX filers reported votes at the meeting of 27 Mar 2026. The filings show 4 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Kobayashi Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Kobayashi Pharmaceutical Co., Ltd. with a meeting date within three days of 27 Mar 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .